Aravive, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization
Write-off of acquired in-process research & development
Loss on impairment of long-lived assets
Stock-based compensation expense
Write-off lease receivable/prepaid commission assets
Write-off of lease receivable/prepaid commission assets
Warrant issuance costs
Warrant liability fair value adjustment

Changes in assets and liabilities
Prepaid expenses and other assets
Accounts payable
Deferred revenue
Accrued liabilities
Accrued and other liabilities
Net cash used in operating activities

Cash flows from investing activities
Purchase of property and equipment
Cash paid to acquire in-process research & development
Cash acquired in the merger transaction
Net cash used in investing activities

Cash flows from financing activities
Inducement on build-to-suit lease obligation
Proceeds from issuance of common stock in connection with employee benefit plans
Proceeds from issuance of common stock in connection with exercise of options
Proceeds from issuance of common stock and common stock warrants, net of issuance costs
Direct Offering
Private Placement
Proceeds from issuance of common stock in at the market offering
Direct Offering
At-the-market Offering
Total proceeds from issuance of common stock in at the market offering
Proceeds from issuance of common stock in private placement, net of issuance costs of $78
Net cash provided by financing activities
Net change in cash, cash equivalents, and restricted cash
Issuance of common stock for the merger transaction
Right-of-use asset acquired through operating lease
Property and equipment recorded upon adoption of ASU 2016-02
Cash, cash equivalents, and restricted cash at beginning of period
Cash, cash equivalents, and restricted cash at end of period

Supplemental disclosure of noncash items
Right-of-use asset acquired through operating lease
Reclass to additional paid-in-capital upon exercise

Comments